摘要
Correspondence to:Prof.Dr.Ira-Ida Skvortsova,Laboratory for Experimental and Translational Research on Radiation Oncology(EXTRO-Lab),Department of Therapeutic Radiology and Oncology,Innsbruck Medical University,Anichstr.35,A-6020 Innsbruck,Austria.E-mail:Ira.Skvortsova@i-med.ac.at;Ira.Skvortsova@tirol-kliniken.atA1 Proteomics identification of protein biomarkers and signaling pathways for prostate cancer radioresistance therapy Lei Chang1,2,Peter Graham1,2,Jingli Hao1,2,Valerie Wasinger3,4,Jie Ni1,2,Julia Beretov1,2,5,Junli Deng1,2,Joseph Bucci1,2,David Malouf6,David Gillatt6,7,Yong Li1,21Cancer Care Centre,St.George Hospital,Kogarah,Australia;2St.George and Sutherland Clinical School,Faculty of Medicine,UNSW,Kensington,Australia;3Bioanalytical Mass Spectrometry Facility,Mark Wainwright Analytical Centre,UNSW,Kensington,Australia;4School of Medical Science,UNSW,Kensington,Australia;5SEALS,Anatomical Pathology,St.George Hospital,Kogarah,Australia;6Department of Urology,St.George Hospital,Kogarah,Australia;7Australian School of Advanced Medicine,Macquarie University,Sydney,Australia Background:Radioresistance is a major problem in prostate cancer(CaP)radiotherapy(RT).
